about
Broad-Spectrum Drugs Against Viral AgentsHMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen.Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODNActivity of the HMGB1-derived immunostimulatory peptide Hp91 resides in the helical C-terminal portion and is enhanced by dimerizationTLR9 mediates S. aureus killing inside osteoblasts via induction of oxidative stress.Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probesVaccination with the ML0276 antigen reduces local inflammation but not bacterial burden during experimental Mycobacterium leprae infection.CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer.Systematic identification of small molecule adjuvants.CpG oligodeoxynucleotides as immunotherapy in cancer.Immunogenicity of multi-epitope-based vaccine candidates administered with the adjuvant Gp96 against rabies.Rapid assembly of the doubly-branched pentasaccharide domain of the immunoadjuvant jujuboside A via convergent B(C6F5)3-catalyzed glycosylation of sterically-hindered precursors.Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections.CD8+ T-Cell Tolerance can be Broken by an Adenoviral Vaccine While CD4+ T-Cell Tolerance is Broken by Additional Co-administration of a Toll-Like Receptor Ligand
P2860
Q27487859-DE885D08-10D9-4EF2-914F-D7FE6CB2CFE5Q34238526-AE59128B-1D62-4018-8E53-2E12F0C7B6DEQ35174485-CAB78B90-27AA-4535-8203-EAEB16251B89Q35903765-E55EDF7E-03D3-41FB-8126-E4B4602FFEE7Q36156486-DC3E94E1-5CFA-47E5-8449-A0F7164B6329Q36216866-4CAA94E1-0CAD-4C5B-9D1A-8F26909CD264Q37451046-856A1DD8-387A-4550-9C88-3E5F2641EA00Q37568374-A5FA6030-4E23-4E6B-8CE8-DA4A94E6829CQ38020881-4415269C-1402-481C-A3D4-A28B4F9A7B63Q38570179-9EB8AF82-8912-42B6-89DE-89076C0AB97FQ40805688-0D995BA5-C8E9-4083-9E2B-3FF242FC7713Q52652417-24E3FBB3-0DA4-457D-B8EC-EE0CDCEF90D9Q55379440-E230CFEE-4F1D-489F-BC8C-358822A8B1FEQ58535137-0A276AC5-695D-4A02-8CA1-CD1F894C841A
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Novel adjuvant systems.
@ast
Novel adjuvant systems.
@en
type
label
Novel adjuvant systems.
@ast
Novel adjuvant systems.
@en
prefLabel
Novel adjuvant systems.
@ast
Novel adjuvant systems.
@en
P356
P1476
Novel adjuvant systems.
@en
P2093
McCluskie MJ
Weeratna RD
P304
P356
10.2174/1568005014605991
P577
2001-11-01T00:00:00Z